Internal Medicine
A topic in the Science corpus, drawn from 324 papers.
Trusted voices in Internal Medicine
Ordered by the trust Internal Medicine's own network concentrates on each researcher, most first.
- J. Heit — trusted by 16 researchers here
- Peter Carmeliet — trusted by 15 researchers here
- Andrew Nicolaides — trusted by 4 researchers here
- Gregory Y. H. Lip — trusted by 5 researchers here
- N. Mackman — trusted by 5 researchers here
- C. Patrono — trusted by 2 researchers here
- R. White — trusted by 3 researchers here
- A. Adamis — trusted by 3 researchers here
- Shu Chien — trusted by 3 researchers here
- J. Chiu — trusted by 3 researchers here
- N. Ferrara — trusted by 2 researchers here
- A. Varki — trusted by 2 researchers here
Most-cited papers in Internal Medicine
Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.
- Dabigatran versus warfarin in patients with atrial fibrillation. (2009, New England Journal of Medicine) — 9,875 citations
- Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. (2010) — 6,747 citations
- 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) (2019, European Respiratory Journal) — 4,847 citations
- Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. (2014, Stroke) — 4,662 citations
- Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. (2012, Chest) — 4,568 citations
- 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2018, Stroke) — 4,363 citations
- Angiogenesis in life, disease and medicine (2005, Nature) — 3,551 citations
- The Epidemiology of Venous Thromboembolism (2003, Circulation) — 3,241 citations
- Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation (2001) — 3,080 citations
- Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004, Chest) — 2,925 citations
- Guidelines for the prevention of intravascular catheter-related infections. (2002, American Journal of Infection Control) — 2,643 citations
- Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism (2008) — 2,605 citations
- Dabigatran versus warfarin in the treatment of acute venous thromboembolism. (2009, New England Journal of Medicine) — 2,549 citations
- Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012, Chest) — 2,418 citations
- Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients (2010, Journal of Thrombosis and Haemostasis) — 2,386 citations
- Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. (2003, New England Journal of Medicine) — 2,379 citations
- Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. (2000, Archives of Internal Medicine) — 2,284 citations
- Oral rivaroxaban for symptomatic venous thromboembolism. (2010, New England Journal of Medicine) — 2,252 citations
- Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives (2011, Physiological Reviews) — 2,222 citations
- COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up (2020, Journal of the American College of Cardiology) — 2,222 citations
- Oral apixaban for the treatment of acute venous thromboembolism. (2013, New England Journal of Medicine) — 2,195 citations
- Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). (2008, Chest) — 2,089 citations
- Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012, Chest) — 2,080 citations
- Development and validation of a predictive model for chemotherapy-associated thrombosis. (2008, Blood) — 2,076 citations
- Platelet activation and atherothrombosis. (2007, New England Journal of Medicine) — 2,075 citations
- Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension: A Scientific Statement From the American Heart Association (2011, Circulation) — 2,052 citations
- Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (2012, Chest) — 1,996 citations
- Revision of the CEAP classification for chronic venous disorders: consensus statement. (2004, Journal of Vascular Surgery) — 1,915 citations
- Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. (2002, Blood) — 1,875 citations
- Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. (2004, New England Journal of Medicine) — 1,840 citations
- Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. (2013, New England Journal of Medicine) — 1,829 citations
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy (2020, Thrombosis Research) — 1,804 citations
- Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. (2001, Chest) — 1,780 citations
- Thrombosis as an intravascular effector of innate immunity (2012, Nature reviews. Immunology) — 1,769 citations
- Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo (2012, Journal of Experimental Medicine) — 1,763 citations
- Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. (2012, New England Journal of Medicine) — 1,719 citations
- [Oral Rivaroxaban for the treatment of symptomatic pulmonary embolism]. (2013, Revista clínica española (Ed. impresa)) — 1,685 citations
- Oral rivaroxaban for symptomatic venous thromboembolism. (2011, New England Journal of Medicine) — 1,683 citations
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer (2000) — 1,672 citations
- Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia (2020, Journal of Thrombosis and Haemostasis) — 1,663 citations
- Prognosis of cancers associated with venous thromboembolism. (2000, New England Journal of Medicine) — 1,611 citations
- Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy (2007, Journal of Thrombosis and Haemostasis) — 1,607 citations
- Contribution of platelets to tumour metastasis (2011, Nature Reviews. Cancer) — 1,595 citations
- 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association… (2008, Circulation) — 1,591 citations
- Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke… (2006, Stroke) — 1,570 citations
- Laboratory haemostasis monitoring in COVID‐19 (2020, Journal of Thrombosis and Haemostasis) — 1,565 citations
- Idarucizumab for Dabigatran Reversal. (2015, New England Journal of Medicine) — 1,551 citations
- Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. (2001, Chest) — 1,534 citations
- Risk factors for venous thromboembolism. (2003, Clinics in Chest Medicine) — 1,520 citations
- Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical… (2001, Annals of Internal Medicine) — 1,486 citations
Most active researchers
By papers in this topic: a volume measure, not trust.
- G. Agnelli — 20 papers
- G. Raskob — 15 papers
- S. Schulman — 14 papers
- H. Büller — 14 papers
- M. Lassen — 13 papers
- J. Heit — 13 papers
- Samuel Z. Goldhaber — 12 papers
- A. Gallus — 10 papers
- M. Cushman — 9 papers
- A. Turpie — 9 papers
- B. Eriksson — 8 papers
- K. Bauer — 8 papers